Anemia, Hemolytic, Autoimmune: Autoimmune hemolytic anemia (AIHA) is an autoimmune disorder in which various types of auto-antibodies are directed against red blood cells causing their survival to be shortened and resulting in hemolytic anemia.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1342 |
4. Check minimum number of eventsNone |
1342 |
5. Include endpointsNone |
1342 |
6. Filter based on genotype QC (FinnGen only) |
1342 |
Control definitions (FinnGen only)
- Control exclude
- D3_APLASTICANDOTHANAEMIA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D60-D64
- Name in latin
- Anaemia posthaemorrhagica acuta
Similar endpoints
↥List of similar endpoints to
Acute posthaemorrhagic anaemia
based on the number of shared cases.
Similar with more cases:
- Aplastic and other anaemias
- Anaemias
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 15654 | 8391 | 7003 |
| Only index persons | 10414 | 5848 | 4566 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.22 | 0.24 | 0.20 |
| Only index persons | 0.20 | 0.21 | 0.17 |
| Median age at first event (years) | |||
| Whole population | 73.23 | 75.42 | 70.61 |
| Only index persons | 71.10 | 72.75 | 68.99 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1342 | 632 | 710 |
| Unadjusted period prevalence (%) | 0.27 | 0.22 | 0.31 |
| Median age at first event (years) | 68.11 | 64.57 | 71.27 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1224
- Matched controls
- 12239
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
16384.0
323.0
1116
5
D64.9
ICD-10 Finland
Anaemia, unspecified
34.9
323.0
439
193
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
5.8
169.8
673
2130
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
18.2
129.3
207
135
2851A
ICD-9 Finland
Other and unspecified anaemias, Acute posthaemorrhagic anaemia
+∞
114.4
108
*
K92.1
ICD-10 Finland
Melaena
8.7
112.9
263
371
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
8.7
112.0
261
368
WW500
NOMESCO Finland
Blood transfusion
13.3
93.4
170
147
C03CA01
ATC
furosemide; systemic
3.0
73.0
656
3369
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
11.3
71.2
139
137
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.3
67.2
288
822
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.8
66.8
339
1125
UJF32
NOMESCO Finland
Coloscopy
3.1
61.9
451
1949
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
55.6
356
1383
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
50.2
368
1551
I50.9
ICD-10 Finland
Heart failure, unspecified
2.9
47.9
354
1496
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
44.5
625
3745
A02BC02
ATC
pantoprazole; systemic
2.4
44.2
845
5894
K92.0
ICD-10 Finland
Haematemesis
8.0
43.1
101
136
ZXD05
NOMESCO Finland
Urgent procedure
2.4
43.0
485
2585
WX892
NOMESCO Finland
Monitored bed care
4.3
40.7
164
427
TPH07
NOMESCO Finland
Cathetrisation of artery
3.5
39.6
206
668
UJF92
NOMESCO Finland
Capsular endoscopy
14.9
38.6
65
46
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
11.5
38.0
72
66
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
37.1
228
833
B01AA03
ATC
warfarin; systemic
2.4
36.9
431
2296
JN3AD
NOMESCO Finland
Abdominal CT examination
4.0
35.5
153
422
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.4
34.9
135
336
C03DA01
ATC
spironolactone; oral
3.0
34.1
228
878
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
9.7
33.9
70
76
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.8
33.5
154
449
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.2
33.4
443
2480
M04AA01
ATC
allopurinol; systemic
2.7
32.6
257
1095
K55.8
ICD-10 Finland
Other vascular disorders of intestine
40.2
31.3
39
10
AA1AD
NOMESCO Finland
CT of head and brain
2.3
31.1
370
1954
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.2
31.0
180
628
B01AB05
ATC
enoxaparin; parenteral
2.2
30.3
420
2376
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
4.2
30.2
120
306
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.2
30.0
177
621
TK800
NOMESCO Finland
Hemodialysis
8.5
29.8
66
81
ZX120
NOMESCO Finland
Intravenous
3.2
29.6
169
579
3AC01
NOMESCO Finland
NA
16.4
28.7
46
29
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
10.4
28.4
56
56
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
27.9
347
1854
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.7
27.7
65
88
WX872
NOMESCO Finland
Intensive care
4.2
27.5
110
282
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
4.0
27.3
114
304
B03XA02
ATC
darbepoetin alfa; parenteral
9.3
27.2
57
64
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
27.2
416
2428
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
26.8
138
439
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.9
26.7
182
704
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.7
26.4
120
345
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
26.3
279
1376
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
26.3
279
1378
A11CC03
ATC
alfacalcidol; systemic
7.5
26.0
62
86
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.3
25.7
100
250
I50.0
ICD-10 Finland
Congestive heart failure
2.7
25.5
189
768
UJD02
NOMESCO Finland
Gastroscopy
3.9
25.2
108
295
WX882
NOMESCO Finland
High dependency care
5.9
25.1
72
129
UJF02
NOMESCO Finland
Peroral enteroscopy
26.8
24.9
34
13
B82
ICPC
Anaemia other/unspecified
7.2
24.1
59
85
JN4BD
NOMESCO Finland
Extensive body CT
2.7
24.1
179
724
N02AX02
ATC
tramadol; systemic, rectal
1.9
24.0
541
3618
K25.4
ICD-10 Finland
Gastric ulcer, Chronic or unspecified with haemorrhage
11.1
23.7
45
42
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
17.3
23.6
37
22
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
6.9
23.4
59
89
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.8
23.4
104
293
Z2446
NOMESCO Finland
Social worker
3.6
23.0
107
313
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
23.0
222
1040
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.3
23.0
237
1145
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
23.0
293
1562
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
8.5
22.8
50
61
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.1
22.5
327
1844
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.0
22.5
398
2423
C07AB07
ATC
bisoprolol; oral
1.8
22.3
662
4816
UJF30
NOMESCO Finland
Ileoscopy through colon
3.1
21.8
129
452
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
19.3
21.3
32
17
127
Kela drug reimbursment
Transplant complication
11.8
21.3
39
34
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
21.1
131
474
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
20.8
232
1161
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.4
20.8
77
184
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
20.7
417
2640
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.1
20.2
80
204
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
8.2
20.1
45
57
J01MA12
ATC
levofloxacin; systemic
2.1
20.0
269
1457
C01DA14
ATC
isosorbide mononitrate; oral
2.0
19.8
312
1801
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.4
19.5
100
316
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
7.3
19.5
47
67
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
6.8
19.3
49
75
N19
ICD-10 Finland
Unspecified kidney failure
4.0
19.2
79
208
R50.9
ICD-10 Finland
Fever, unspecified
2.3
19.2
193
917
XW000
NOMESCO Finland
Bone marrow biopsy
4.2
19.1
73
180
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.1
19.1
249
1329
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.9
19.0
346
2102
A41.9
ICD-10 Finland
Sepsis, unspecified
3.8
18.9
82
227
D64.8
ICD-10 Finland
Other specified anaemias
9.5
18.7
38
41
JDA42
NOMESCO Finland
Other endoscopic haemostatic procedure in stomach or pylorus
19.1
18.7
28
15
JN4AD
NOMESCO Finland
Body CT examination
2.9
18.5
117
428
A06AD11
ATC
lactulose; oral
2.0
18.5
265
1467
Z49.1
ICD-10 Finland
Extracorporeal dialysis
8.9
18.5
39
45
TKC20
NOMESCO Finland
Catheterisation of bladder
2.7
18.1
132
526
WX002
NOMESCO Finland
Sedation and analgesia
2.0
17.9
250
1369
I35.0
ICD-10 Finland
Aortic (valve) stenosis
2.7
17.7
131
528
A02BC01
ATC
omeprazole; systemic
1.8
17.6
381
2445
A12AA04
ATC
calcium carbonate; oral
7.5
17.5
41
56
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
29.2
17.4
23
8
I25.2
ICD-10 Finland
Old myocardial infarction
2.4
17.3
152
673
F10.25
ICD-10 Finland
Alcohol dependence continuous use
7.1
17.3
42
61
A46
ICD-10 Finland
Erysipelas
2.1
17.1
209
1081
Z3226
NOMESCO Finland
Physiotherapist
2.0
16.9
234
1274
Z94.0
ICD-10 Finland
Kidney transplant status
12.9
16.7
29
23
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.1
16.6
65
164
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.5
16.5
132
554
D50.8
ICD-10 Finland
Other iron deficiency anaemias
7.7
16.5
38
51
N05CF01
ATC
zopiclone; oral
1.7
16.4
438
2988
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
16.3
746
5918
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
13.0
16.2
28
22
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.4
16.1
81
253
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
16.1
211
1120
C01AA05
ATC
digoxin; systemic
2.1
16.1
195
1002
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.7
16.1
55
122
ZXE20
NOMESCO Finland
More than three and less than five hours
2.1
16.0
191
976
I50.1
ICD-10 Finland
Left ventricular failure
2.7
15.8
112
440
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.9
15.7
65
173
R53
ICD-10 Finland
Malaise and fatigue
1.9
15.7
278
1656
R04.0
ICD-10 Finland
Epistaxis
2.6
15.6
120
493
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
8.7
15.5
33
39
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.8
15.5
330
2090
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.8
15.5
100
372
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.3
15.4
57
137
K22.1
ICD-10 Finland
Ulcer of oesophagus
5.4
15.4
46
88
205
Kela drug reimbursment
Chronic hypertension
1.7
15.4
442
3066
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
15.4
196
1028
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
8.8
15.3
32
37
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.2
15.1
33
41
J01MA14
ATC
moxifloxacin; systemic
2.5
15.0
123
524
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
15.0
141
644
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.8
14.9
102
390
R4110
NOMESCO Finland
Physiotherapy
1.8
14.8
308
1933
J01MA02
ATC
ciprofloxacin; systemic
1.7
14.8
488
3506
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
14.8
416
2861
N18.8
ICD-10 Finland
Other chronic renal failure
4.1
14.7
58
148
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
14.7
209
1147
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.2
14.7
77
249
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.7
14.6
377
2527
Z3231
NOMESCO Finland
Registered nurse
1.8
14.5
326
2092
B01AB10
ATC
tinzaparin; parenteral
2.8
14.4
97
369
A02BC03
ATC
lansoprazole; oral
1.7
14.3
355
2349
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.6
14.1
108
443
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
14.0
112
471
J01DB01
ATC
cefalexin; oral
1.7
14.0
884
7481
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.0
14.0
56
145
C09AA05
ATC
ramipril; oral
1.7
13.9
350
2323
R06.0
ICD-10 Finland
Dyspnoea
1.7
13.9
317
2041
L04AA06
ATC
mycophenolic acid; systemic
7.0
13.7
33
48
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.3
13.6
125
566
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.6
13.5
46
102
N02AA05
ATC
oxycodone; systemic
1.9
13.2
208
1181
A10AE04
ATC
insulin glargine; parenteral
2.3
13.2
132
620
K26.0
ICD-10 Finland
Duodenal ulcer, acute with haemorrhage
7.0
13.2
32
47
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.5
13.2
105
439
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.6
13.1
95
377
F10.24
ICD-10 Finland
Alcohol depence active use
8.4
13.1
28
34
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.1
13.0
163
846
A04
ICPC
Weakness/tiredness general
2.1
13.0
163
847
R18
ICD-10 Finland
Ascites
5.1
12.8
40
81
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
11.7
12.8
23
20
E87.5
ICD-10 Finland
Hyperkalaemia
5.3
12.8
38
73
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.9
12.8
76
269
I50
ICD-10 Finland
Heart failure
3.2
12.7
67
218
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.4
12.7
114
510
JAH00
NOMESCO Finland
Laparotomy
3.8
12.6
53
144
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
5.4
12.6
37
70
B02AA02
ATC
tranexamic acid; systemic
2.1
12.3
155
808
K55.2
ICD-10 Finland
Angiodysplasia of colon
8.5
12.3
26
31
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
9.8
12.3
24
25
ZXE00
NOMESCO Finland
One hour or less
1.6
12.2
438
3173
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.8
12.2
81
307
C07AB02
ATC
metoprolol; systemic
1.7
12.2
318
2119
PC1CC
NOMESCO Finland
Very extensive angiography of aorta and abdominal arteries
16.0
12.2
19
12
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.8
12.1
76
278
C08CA01
ATC
amlodipine; oral
1.6
12.1
452
3309
S97
ICPC
Chronic ulcer skin
2.7
12.1
86
337
J01FF01
ATC
clindamycin; systemic
1.7
12.1
294
1920
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
27.0
12.1
16
6
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
12.0
374
2613
V03AE01
ATC
polystyrene sulfonate; oral
6.1
12.0
32
54
B01AC04
ATC
clopidogrel; oral
1.8
11.9
220
1318
JN4CD
NOMESCO Finland
Very extensive body CT
3.0
11.9
68
234
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.7
11.8
79
301
E86
ICD-10 Finland
Volume depletion
3.5
11.7
54
159
M10.9
ICD-10 Finland
Gout, unspecified
2.4
11.7
102
448
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.1
11.7
31
52
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.3
11.7
107
481
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
16.6
11.7
18
11
B80
ICPC
Iron deficiency anaemia
5.6
11.7
33
60
Z2221
NOMESCO Finland
Medical doctor
1.7
11.7
307
2044
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.2
11.6
119
564
AN1
HP
Coronary angiography
1.9
11.6
181
1023
JFB00
NOMESCO Finland
Partial resection of small intestine
5.2
11.6
35
69
I20.09
ICD-10 Finland
Unstable angina
2.3
11.5
104
466
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.9
11.5
37
78
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.2
11.5
43
106
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
7.6
11.5
26
35
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
121.1
11.4
12
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
11.4
146
765
A12BA01
ATC
potassium chloride; oral
2.3
11.4
105
474
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
11.4
186
1066
K26.4
ICD-10 Finland
Duodenal ulcer, chronic or unspecified with haemorrhage
11.9
11.3
20
17
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
11.3
206
1227
K29.0
ICD-10 Finland
Acute haemorrhagic gastritis
9.0
11.3
23
26
Z49.0
ICD-10 Finland
Preparatory care for dialysis
9.0
11.3
23
26
PG1QT
NOMESCO Finland
Very extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
35.4
11.3
14
*
K70.1
ICD-10 Finland
Alcoholic hepatitis
9.7
11.3
22
23
L04AX01
ATC
azathioprine; systemic
3.2
11.2
58
187
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.3
11.2
56
176
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
11.2
213
1288
SPAT1262
SPAT
Handing over of treatment supplies
1.8
11.1
214
1301
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.7
11.1
47
130
N03AX16
ATC
pregabalin; oral
1.7
11.0
257
1652
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
11.0
327
2245
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
11.0
347
2420
K70.4
ICD-10 Finland
Alcoholic hepatic failure
14.0
11.0
18
13
RS221
NOMESCO Finland
NA
6.3
10.9
28
45
R55
ICD-10 Finland
Syncope and collapse
1.9
10.9
156
853
N02BE01
ATC
paracetamol; systemic, rectal
1.6
10.8
961
8500
A07AA09
ATC
vancomycin; oral
5.3
10.8
32
62
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.1
10.8
131
672
D50
ICD-10 Finland
Iron deficiency anaemia
5.9
10.8
29
50
SPAT1254
SPAT
Administration of medicine
1.8
10.8
200
1199
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.8
10.7
70
261
WX402
NOMESCO Finland
General anaesthesia
1.9
10.6
154
847
N17.8
ICD-10 Finland
Other acute renal failure
5.6
10.6
30
55
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
10.6
112
539
P15
ICPC
Chronic alcohol abuse
4.6
10.5
35
77
PD5BD
NOMESCO Finland
Extensive CT of aorta
4.1
10.5
40
101
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
10.4
341
2395
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
2.2
10.4
102
477
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
10.4
208
1275
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.0
10.4
59
202
PD1CD
NOMESCO Finland
Very extensive CT of abdominal aorta and branches
16.2
10.4
16
10
K72.9
ICD-10 Finland
Hepatic failure, unspecified
12.2
10.4
18
15
K29.2
ICD-10 Finland
Alcoholic gastritis
32.8
10.3
13
*
F10.20
ICD-10 Finland
Alcohol dependence currently independent
5.4
10.3
30
57
SPAT1255
SPAT
Intravenous administration of medicine
2.3
10.3
91
405
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.8
10.3
65
240
JDA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in stomach or pylorus
19.0
10.3
15
8
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.8
10.3
66
247
81
HP
Angiography of the heart and coronary arteries
2.1
10.2
117
586
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.9
10.2
63
227
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
10.2
73
291
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
5.7
10.1
28
50
A28
ICPC
Limited function/disability NOS
1.7
10.1
215
1342
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.2
10.1
106
509
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.9
10.0
40
105
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
10.0
237
1523
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
3.5
10.0
45
131
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.9
9.9
31
64
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
9.9
227
1446
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.1
9.9
53
176
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.1
9.8
53
177
R11
ICD-10 Finland
Nausea and vomiting
2.1
9.8
109
537
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.4
9.8
82
354
N05BA04
ATC
oxazepam; oral
1.6
9.8
275
1856
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
9.8
111
554
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
9.7
464
3543
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
13.5
9.7
16
12
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
10.1
9.5
18
18
V03AE02
ATC
sevelamer; oral
15.2
9.5
15
10
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
15.2
9.5
15
10
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
9.5
476
3675
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.5
9.4
73
301
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.3
9.4
90
415
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
4.6
9.4
31
68
207
Kela drug reimbursment
Chronic arrhythmias
1.7
9.4
207
1301
K76.7
ICD-10 Finland
Hepatorenal syndrome
30.3
9.4
12
*
A07AA11
ATC
rifaximin; oral
30.3
9.4
12
*
WX725
NOMESCO Finland
Noninvasive ventilation
2.7
9.4
61
230
2859X
ICD-9 Finland
Other and unspecified anaemias, Anaemia, unspecified[ANAEMIA NUD]
+∞
9.4
9
*
WX704
NOMESCO Finland
Intubation
2.3
9.4
85
384
A10AE05
ATC
insulin detemir; parenteral
2.5
9.3
71
293
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.0
9.3
122
645
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.1
9.3
28
56
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
6.5
9.3
23
36
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
3.8
9.3
38
103
N05BA02
ATC
chlordiazepoxide; systemic
3.8
9.3
38
103
A10BH01
ATC
sitagliptin; oral
2.0
9.2
118
618
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
9.2
396
2952
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
7.8
9.1
20
26
SPAT1104
SPAT
Monitoring of emergency patient
2.3
9.1
86
396
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.2
9.1
90
420
C07AG02
ATC
carvedilol; oral
2.2
9.0
90
426
JDA35
NOMESCO Finland
Endoscopic contact coagulation in stomach or pylorus
18.7
8.9
13
7
A41.8
ICD-10 Finland
Other specified sepsis
4.0
8.9
34
87
C09AA02
ATC
enalapril; systemic
1.6
8.8
271
1865
PD5AD
NOMESCO Finland
CT of aorta
4.6
8.8
29
64
WX730
NOMESCO Finland
Conventional respirator
4.1
8.8
33
83
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.9
8.8
34
88
H02AB06
ATC
prednisolone; systemic
1.4
8.7
516
4094
PC4SC
NOMESCO Finland
Bowel angiography with X-ray
50.3
8.7
10
*
R31
ICD-10 Finland
Unspecified haematuria
1.9
8.6
138
785
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
8.6
298
2107
137
Kela drug reimbursment
Uraemia requiring dialysis
8.3
8.6
18
22
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.6
8.6
62
249
E87.6
ICD-10 Finland
Hypokalaemia
3.0
8.5
49
170
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.2
8.4
43
139
D64.0
ICD-10 Finland
Hereditary sideroblastic anaemia
+∞
8.3
8
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
4.3
8.3
29
68
TK810
NOMESCO Finland
Hemofiltration
9.5
8.3
16
17
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.2
8.3
78
360
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.2
8.2
84
399
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
4.6
8.2
27
60
D70.89
ICD-10 Finland
Neutropenic splenomegaly
6.5
8.2
20
31
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.8
8.2
33
89
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
5.4
8.2
23
43
K26.9
ICD-10 Finland
Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation
5.7
8.1
22
39
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
17.3
8.1
12
7
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.5
8.1
59
239
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
8.1
253
1747
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
9.0
8.0
16
18
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
5.9
8.0
21
36
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.6
8.0
55
215
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.5
8.0
59
241
201
Kela drug reimbursment
Chronic cardiac insufficiency
2.0
7.9
100
522
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
7.9
157
955
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
4.3
7.9
28
67
B03XA01
ATC
erythropoietin; parenteral
5.4
7.8
22
41
A10BA02
ATC
metformin; oral
1.5
7.8
329
2421
GD1AD
NOMESCO Finland
Thorax CT examination
2.6
7.8
57
229
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
10.9
7.8
14
13
Z49.2
ICD-10 Finland
Other dialysis
9.5
7.8
15
16
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.0
7.8
18
26
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.5
7.7
34
99
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
3.5
7.7
34
99
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
7.7
148
893
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.2
7.6
78
373
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.7
7.6
50
192
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.9
7.6
29
75
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
25.2
7.6
10
*
N07BB01
ATC
disulfiram; oral
3.0
7.6
43
148
5781A
ICD-9 Finland
Gastro-intestinal haemorrhage, Melaena[MELAENA]
8.9
7.5
15
17
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
5.5
7.5
21
39
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.7
7.5
48
179
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
2.1
7.5
86
429
P01AB01
ATC
metronidazole; oral, rectal
1.4
7.5
379
2893
PWE00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system
7.2
7.5
17
24
K29.6
ICD-10 Finland
Other gastritis
5.1
7.4
22
44
JCA32
NOMESCO Finland
Endoscopic injection in oesophagus
80.5
7.4
8
*
K22.6
ICD-10 Finland
Gastro-oesophageal laceration-haemorrhage syndrome
7.7
7.4
16
21
JFA45
NOMESCO Finland
Endoscopic contact coagulation in colon
7.7
7.4
16
21
K86.1
ICD-10 Finland
Other chronic pancreatitis
6.0
7.4
19
32
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
7.4
330
2459
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.1
7.3
85
429
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.3
7.3
67
306
N06AX11
ATC
mirtazapine; oral
1.5
7.3
314
2319
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
7.3
200
1332
K56.7
ICD-10 Finland
Ileus, unspecified
3.7
7.3
30
83
N05CD07
ATC
temazepam; oral
1.6
7.3
178
1153
L04AD01
ATC
ciclosporin; systemic
4.5
7.3
24
54
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
2.3
7.3
66
300
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.6
7.3
51
203
ZXE90
NOMESCO Finland
More than 22 hours
5.2
7.3
21
41
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
15.8
7.2
11
7
V03AE03
ATC
lanthanum carbonate; oral
15.8
7.2
11
7
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.0
7.2
93
491
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.2
7.2
68
314
N05BA01
ATC
diazepam; systemic, rectal
1.7
7.2
157
985
J01DA01
ATC
[U] cefalexin; systemic
1.4
7.2
687
5873
JFB30
NOMESCO Finland
Right hemicolectomy
4.0
7.2
27
69
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
3.7
7.2
29
79
A02BC05
ATC
esomeprazole; systemic
1.4
7.2
415
3247
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.9
7.2
42
150
C02EA02
ATC
NA
2.1
7.1
81
406
L28
ICPC
Limited function/disability (L)
1.6
7.1
198
1326
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
3.9
7.1
27
70
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
6.1
7.1
18
30
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
5.7
7.1
19
34
NF1AA
NOMESCO Finland
Hip X-ray examination
1.8
7.1
112
635
SPAT1088
SPAT
Blood transfusion
8.8
7.1
14
16
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.8
7.0
114
652
R60.0
ICD-10 Finland
Localized oedema
1.8
7.0
131
781
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.8
7.0
121
706
N05AH04
ATC
quetiapine; oral
1.7
7.0
144
887
JDA32
NOMESCO Finland
Endoscopic injection in stomach or pylorus
7.0
7.0
16
23
N18.0
ICD-10 Finland
End-stage renal disease
4.5
7.0
23
52
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
4.3
6.9
24
57
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.3
6.9
33
103
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
7.6
6.9
15
20
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
13.9
6.9
11
8
Z94.4
ICD-10 Finland
Liver transplant status
13.9
6.9
11
8
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.4
6.9
31
93
XCK10
NOMESCO Finland
Photography of fundus of eye
1.8
6.8
119
695
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
3.0
6.8
36
121
F10.09
ICD-10 Finland
Alcohol intoxication UNS
3.9
6.8
26
68
L04AA01
ATC
[U] ciclosporin; systemic
4.6
6.8
22
49
F60.9
ICD-10 Finland
Personality disorder, unspecified
5.3
6.8
19
36
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.6
6.8
47
184
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
6.8
321
2416
I20.01
ICD-10 Finland
Unstable angina
2.5
6.8
49
200
Z72.8
ICD-10 Finland
Other problems related to lifestyle
16.8
6.7
10
6
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
2.2
6.7
67
317
R10.0
ICD-10 Finland
Acute abdomen
2.9
6.7
39
138
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.3
6.7
59
263
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
2.3
6.7
60
272
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.8
6.7
111
639
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
4.1
6.7
24
59
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.1
6.7
69
331
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
3.0
6.7
35
117
X78
ICD-10 Finland
Intentional self-harm by sharp object
22.6
6.7
9
*
WX740
NOMESCO Finland
Nitrogen oxide therapy
22.6
6.7
9
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.4
6.7
53
225
R4190
NOMESCO Finland
Nutritional therapy
3.1
6.7
34
112
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
6.5
6.6
16
25
K26.3
ICD-10 Finland
Duodenal ulcer, acute without haemorrhage or perforation
6.5
6.6
16
25
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
2.2
6.6
66
311
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.9
6.6
38
133
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.6
6.6
162
1046
ZZA00
NOMESCO Finland
Split skin graft
2.6
6.6
44
171
S18
ICPC
Laceration/cut
1.4
6.6
419
3320
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
5.5
6.6
18
33
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
5.5
6.6
18
33
XF640
NOMESCO Finland
NA
2.7
6.6
43
164
NB6AA
NOMESCO Finland
Humerus X-ray examination
3.6
6.6
28
80
L03AA02
ATC
filgrastim; parenteral
3.1
6.6
33
107
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.5
6.6
222
1555
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
3.0
6.6
35
119
R33
ICD-10 Finland
Retention of urine
1.8
6.5
115
676
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
4.4
6.5
22
51
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
2.1
6.5
70
341
-50
ICPC
Medication/prescr/renewal
2.4
6.5
50
210
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.9
6.5
85
451
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.6
6.5
27
76
U14
ICPC
Kidney symptom/complaint
4.0
6.5
24
61
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
2.3
6.5
56
250
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
3.3
6.5
30
92
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
2.4
6.5
52
222
C10AA01
ATC
simvastatin; oral
1.4
6.5
521
4300
N03AX14
ATC
levetiracetam; systemic
3.4
6.5
29
87
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.1
6.4
70
347
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
4.7
6.4
20
43
B01AB04
ATC
dalteparin; parenteral
2.1
6.4
65
312
I78.0
ICD-10 Finland
Hereditary haemorrhagic telangiectasia
14.4
6.4
10
7
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
2.0
6.4
76
390
R4120
NOMESCO Finland
Occupational therapy
2.1
6.4
65
313
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
3.0
6.4
34
116
C08DB01
ATC
diltiazem; oral
1.9
6.3
95
528
196
Kela drug reimbursment
Paricalcitol and cinacalcet
8.2
6.3
13
16
ZX112
NOMESCO Finland
Subcutaneous
3.2
6.3
30
94
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.7
6.3
41
156
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
6.0
6.3
16
27
Z39.0
ICD-10 Finland
Care and examination immediately after delivery
11.1
6.3
11
10
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.9
6.3
89
485
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
9.3
6.3
12
13
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.4
6.3
51
221
JCA20
NOMESCO Finland
Ligature of oesophageal varices
+∞
6.3
6
*
SPAT1263
SPAT
Sampling
1.4
6.2
422
3378
K25.3
ICD-10 Finland
Gastric ulcer, Acute without haemorrhage or perforation
4.3
6.2
21
49
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
4.3
6.2
21
49
K72.1
ICD-10 Finland
Chronic hepatic failure
26.8
6.2
8
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.0
6.2
77
401
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
7.1
6.2
14
20
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
4.0
6.2
23
59
SPAT1234
SPAT
Support of social functional capacity
2.0
6.2
72
364
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
2.5
6.2
47
196
K78
ICPC
Atrial fibrillation/flutter
1.7
6.2
113
672
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
6.1
68
340
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
7.7
6.1
13
17
S70.0
ICD-10 Finland
Contusion of hip
2.3
6.1
55
248
C02AC05
ATC
moxonidine; oral
2.2
6.1
58
271
T90
ICPC
Diabetes non-insulin dependent
1.5
6.1
240
1733
Z53.0
ICD-10 Finland
Procedure not carried out because of contraindication
12.6
6.1
10
8
G72.8
ICD-10 Finland
Other specified myopathies
3.5
6.0
26
76
WX400
NOMESCO Finland
Inhalation anesthesy
2.5
6.0
44
181
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.4
6.0
49
211
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3027945) Reticulocytes/100 erythrocytes in Blood
368
1097
4.24
110.77
3.2
2.2
%
2.2
1.7
7.65
310
952
(3004789) Transferrin [Mass/volume] in Serum or Plasma
412
1362
3.92
106.85
4.5
2.1
g/l
2.3
2.3
0.02
384
1241
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
605
2583
3.44
105.53
4.0
2.0
mg/l
3.7
3.0
7.09
535
2136
(3022948) Iron [Moles/volume] in Serum or Plasma
437
1515
3.79
105.53
4.6
2.1
umol/l
9.5
12.6
18.66
404
1378
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
394
1274
3.96
105.33
4.9
2.2
%
18.1
22.5
7.20
331
1067
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
199
382
5.94
101.34
2.0
1.9
g/l
1.4
1.5
0.60
163
325
(3020779) Urea [Moles/volume] in Serum or Plasma
289
850
4.06
86.91
12.0
6.0
mmol/l
13.1
10.8
3.82
267
804
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
324
1052
3.74
84.29
4.2
3.8
u/l
260.7
247.9
0.49
295
985
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
141
245
6.31
79.04
3.5
2.3
g/l
3.4
3.6
0.69
133
236
(3012095) Magnesium [Moles/volume] in Serum or Plasma
399
1538
3.27
78.61
5.1
2.9
mmol/l
0.8
0.8
2.01
371
1419
(3003458) Phosphate [Moles/volume] in Serum or Plasma
349
1289
3.31
73.24
11.4
4.7
mmol/l
1.1
1.0
4.51
323
1174
(3023520) Reticulocytes [#/volume] in Blood
254
791
3.73
69.33
3.3
2.2
e9/l
74.7
67.8
1.73
211
598
(3044640) Blood type and Crossmatch panel - Blood
602
3130
2.67
66.13
5.5
2.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
116
203
6.16
64.32
1.7
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
158
375
4.64
62.14
4.0
2.4
u/ml
0.3
0.4
1.00
98
217
(3018677) aPTT in Platelet poor plasma by Coagulation assay
375
1571
2.92
62.04
3.7
1.8
s
31.0
29.9
1.41
359
1521
(3023368) Bacteria identified in Blood by Culture
570
3011
2.55
58.96
8.1
4.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
683
3931
2.50
58.63
5.5
2.5
ug/l
167.3
134.2
1.71
626
3547
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
481
2378
2.59
56.76
4.8
2.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
253
889
3.27
56.43
3.3
2.2
g/l
0.2
0.2
4.74
224
827
(3032080) INR in Blood by Coagulation assay
723
4398
2.40
53.16
18.6
10.5
inr
1.4
1.3
0.87
187
1210
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
733
4508
2.38
52.24
7.9
4.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
295
1199
2.87
50.55
9.2
7.5
mmol/l
0.7
1.3
1.42
231
927
(3027801) Oxygen [Partial pressure] in Arterial blood
293
1200
2.84
49.39
9.2
7.4
kpa
11.9
11.7
0.21
270
1135
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
293
1200
2.84
49.39
9.3
7.5
kpa
4.9
5.1
1.57
268
1135
(3024561) Albumin [Mass/volume] in Serum or Plasma
709
4395
2.30
48.31
10.3
4.4
g/l
32.2
34.9
22.78
658
4047
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
211
746
3.17
46.04
2.1
1.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
100
211
5.04
45.04
5.6
2.5
umol/l
40.0
33.3
1.41
83
172
(3016502) Oxygen saturation in Arterial blood
264
1075
2.81
44.63
9.4
7.8
%
95.8
95.3
0.77
247
1033
(3000991) Gas panel - Venous blood
220
828
2.98
42.89
11.6
8.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
150
449
3.64
42.54
7.3
3.4
mmol/l
23.9
24.1
0.31
137
406
(3002032) Base excess in Venous blood by calculation
240
952
2.85
42.48
7.0
3.1
mmol/l
1.3
2.1
2.62
188
744
(3022217) INR in Platelet poor plasma by Coagulation assay
332
1563
2.49
41.57
35.3
29.3
inr
1.6
1.4
0.52
23
187
(3021447) Carbon dioxide [Partial pressure] in Venous blood
238
953
2.82
41.31
7.1
3.1
kpa
5.7
5.8
0.84
223
921
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
770
5161
2.15
40.51
11.4
5.7
umol/l
13.2
12.1
0.98
733
4864
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
100
235
4.52
39.48
4.5
2.0
%
215.4
193.9
1.15
95
220
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
703
4602
2.11
38.72
12.9
5.6
mmol/l
1.2
1.2
8.20
648
4108
(3019309) Folate [Moles/volume] in Red Blood Cells
410
2183
2.26
38.34
2.2
1.8
nmol/l
1185.6
1178.7
0.05
330
1595
(3014111) Lactate [Moles/volume] in Serum or Plasma
224
907
2.76
37.86
8.5
6.7
mmol/l
1.5
1.4
0.70
209
869
(3002173) Hemoglobin [Mass/volume] in Arterial blood
235
977
2.70
37.72
10.2
8.4
g/l
106.2
121.7
22.53
226
939
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
75
148
5.31
36.38
6.7
6.0
iu/ml
504.5
1352.9
0.37
19
19
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
746
5067
2.06
36.33
14.7
6.2
mmol/l
1.2
1.2
8.38
634
4224
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
155
532
3.16
35.18
11.4
10.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
515
3088
2.08
34.91
4.8
2.4
u/l
55.4
57.5
0.66
493
2834
(3042936) Bacteria identified in Isolate by Culture
298
1435
2.38
34.84
3.2
2.0
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
277
1305
2.41
33.94
10.6
6.7
mmol/l
104.3
104.2
0.11
272
1268
(42870588) Differential panel, method unspecified - Blood
515
3121
2.05
33.63
9.5
5.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
652
4308
2.00
33.29
9.8
5.3
%
2.7
2.9
0.71
610
3962
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
134
437
3.30
33.05
2.4
1.7
ug/l
2.3
1.3
0.47
117
370
(3019069) Monocytes/100 leukocytes in Blood
652
4325
1.99
32.74
10.4
5.5
%
9.0
8.8
0.70
611
3998
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
228
998
2.55
32.66
3.4
2.4
ug/l
8.7
6.7
0.38
189
842
(3002030) Lymphocytes/100 leukocytes in Blood
660
4413
1.98
32.21
10.1
5.5
%
22.7
26.7
15.12
611
4060
(3036489) Thrombin time
111
326
3.62
32.21
3.2
1.8
s
22.3
21.8
0.30
104
300
(3018010) Neutrophils/100 leukocytes in Blood
650
4349
1.96
31.41
9.3
5.3
%
61.6
58.2
8.62
602
4022
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
239
1088
2.46
31.40
4.9
2.6
umol/l
9.1
9.4
0.09
206
946
(3022096) Basophils/100 leukocytes in Blood
631
4188
1.96
31.14
10.1
5.3
%
0.6
0.7
1.58
588
3855
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
343
1844
2.16
30.28
2.5
1.8
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
63
126
5.20
30.08
7.5
6.9
mg/l
12.5
12.4
0.03
56
114
(3019060) Gas panel - Arterial blood
177
717
2.69
29.53
7.2
4.8
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
419
2450
2.03
29.42
9.9
3.7
%
79.1
85.7
4.97
402
2385
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
117
384
3.24
28.48
3.1
2.1
ug/l
582.6
550.4
0.05
111
361
(3007853) Bacteria identified in Skin by Aerobe culture
238
1136
2.33
27.88
2.4
1.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
163
662
2.66
26.97
9.6
7.1
mmol/l
24.4
24.6
0.34
150
620
(3013115) Eosinophils [#/volume] in Blood
677
4755
1.86
26.68
9.7
5.3
e9/l
0.2
0.2
0.60
617
4148
(3017143) Hepatitis C virus Ab [Presence] in Serum
187
819
2.49
26.45
2.2
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
142
546
2.79
26.10
10.0
9.6
mmol/l
23.6
24.5
2.06
128
503
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
358
2052
2.02
26.09
2.6
1.6
mg/l
1.6
1.3
0.77
276
1583
(3024354) Oxygen [Partial pressure] in Venous blood
184
806
2.49
26.00
5.4
2.5
kpa
4.6
4.4
0.59
170
779
(3020630) Protein [Mass/volume] in Serum or Plasma
186
825
2.46
25.57
3.1
2.8
g/l
65.3
66.4
0.96
160
740
(3001604) Monocytes [#/volume] in Blood
653
4576
1.83
25.54
9.1
5.2
e9/l
0.6
0.6
2.00
594
3920
(3006315) Basophils [#/volume] in Blood
654
4594
1.83
25.30
9.1
5.2
e9/l
0.0
0.0
1.13
595
3948
(3019198) Lymphocytes [#/volume] in Blood
665
4695
1.83
25.30
9.2
5.3
e9/l
1.6
1.9
6.08
605
4108
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
178
779
2.48
25.17
7.6
3.3
ng/l
162.4
86.2
7.07
151
677
(3014007) Fractional oxyhemoglobin in Arterial blood
156
642
2.62
25.08
10.4
9.2
%
93.7
93.9
0.15
156
636
(40768797) Stomach Pathology biopsy report
243
1224
2.20
24.81
1.4
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
102
335
3.21
24.76
1.4
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
161
679
2.56
24.60
3.2
2.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
140
555
2.70
24.22
8.5
7.5
mmol/l
24.4
25.0
1.10
140
550
(3013650) Neutrophils [#/volume] in Blood by Automated count
737
5420
1.80
23.99
14.6
7.9
e9/l
4.5
4.2
1.86
678
4707
(3026008) Bacteria identified in Urine by Culture
506
3341
1.83
23.52
4.4
3.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
456
2916
1.85
23.52
5.3
3.1
u/l
39.1
34.0
0.89
424
2780
(3024928) Oxygen saturation in Venous blood
75
211
3.71
23.14
4.5
2.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
206
997
2.26
23.08
2.2
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
468
3037
1.83
22.89
8.5
3.6
ph
7.4
7.4
1.61
87
554
(3047181) Lactate [Moles/volume] in Blood
93
308
3.17
22.25
9.4
7.2
mmol/l
1.4
1.4
0.13
80
270
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
244
1282
2.10
22.18
2.3
1.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
782
5930
1.76
22.16
10.1
4.6
mmol/l
7.4
6.8
5.93
743
5545
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
243
1277
2.10
22.07
2.3
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
59
145
4.21
21.94
1.8
1.3
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
28
34
8.39
21.43
3.5
1.4
mg/l
51.8
71.4
1.15
20
25
(3028026) IgM [Mass/volume] in Serum or Plasma
125
500
2.65
21.20
2.6
1.8
g/l
1.6
1.6
0.05
111
455
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
467
3110
1.77
20.44
3.0
2.1
u/l
187.2
238.2
0.84
435
2902
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
52
123
4.36
20.32
1.8
1.3
u/ml
112.4
111.9
0.01
11
22
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
142
618
2.45
20.19
7.5
3.7
mmol/l
1.7
2.0
0.32
108
461
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
84
279
3.15
20.00
2.1
1.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
88
304
3.03
19.59
3.8
3.6
mg/l
49.9
48.1
0.05
65
254
(3034860) Kappa light chains.free [Mass/volume] in Serum
88
304
3.03
19.59
3.8
3.6
mg/l
78.0
73.8
0.06
65
253
(3009343) pH of Capillary blood
144
643
2.39
19.32
7.5
3.7
ph
7.4
7.4
1.22
21
76
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
145
652
2.37
19.15
7.6
3.7
kpa
5.2
5.2
0.15
133
601
(46235355) HIV 1 and 2 tests - Meaningful Use set
218
1162
2.05
18.85
2.3
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
177
874
2.18
18.70
5.3
2.4
u/l
29.6
34.8
1.46
148
735
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
193
988
2.11
18.58
4.1
3.0
ng/l
388.6
228.0
2.91
184
903
(3021879) Hepatitis B virus core Ab [Presence] in Serum
123
522
2.49
18.43
1.5
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
65
194
3.47
18.37
2.0
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
140
632
2.36
18.31
3.4
2.7
g/l
10.9
10.9
0.04
127
567
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
327
2019
1.82
18.12
6.6
4.0
ng/l
628.6
372.9
0.60
293
1678
(40760888) Immunoglobulin light chains.free panel - Serum
69
216
3.31
18.10
4.0
4.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
19
17
11.32
18.01
2.1
1.5
—
—
—
0
0
(3039000) Anion gap in Blood
69
219
3.27
17.71
11.2
8.4
mmol/l
11.2
11.4
0.18
60
198
(3018572) Chloride [Moles/volume] in Blood
69
219
3.27
17.71
11.2
8.4
mmol/l
106.0
105.0
0.77
60
198
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
136
631
2.29
16.66
1.9
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
199
1072
2.01
16.60
3.1
3.8
ug/l
7.6
22.6
1.17
163
886
(3026782) Osmolality of Urine
337
2150
1.76
16.52
4.1
2.7
mosm/kgh2o
511.7
558.4
4.42
299
1809
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
17
15
11.47
16.23
1.2
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
579
4294
1.61
15.80
2.7
2.0
pmol/l
90.0
92.7
0.74
339
2162
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
480
3400
1.64
15.78
4.9
3.0
ng/l
2879.2
1755.1
4.47
421
2936
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
30
55
5.56
15.76
2.9
2.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
23
32
7.30
15.70
3.5
2.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
151
749
2.14
15.68
6.3
3.8
%
0.8
0.9
0.22
54
209
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
69
236
3.03
15.64
1.8
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
139
676
2.18
15.17
5.8
3.7
%
0.8
0.6
0.45
39
146
(40758558) Short blood count panel - Blood
355
2349
1.70
15.06
12.7
6.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
66
225
3.03
15.05
1.9
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
377
2538
1.68
14.97
2.0
1.5
nmol/l
19.1
20.3
0.73
333
2126
(3000850) Epithelial cells [#/volume] in Urine
345
2270
1.70
14.93
4.4
2.5
e6/l
5.8
5.3
0.30
316
1991
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
516
3762
1.60
14.87
5.5
3.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
135
655
2.18
14.81
5.1
2.8
g/l
109.5
128.1
12.97
130
640
(3000093) Morphology [Interpretation] in Blood Narrative
35
78
4.58
14.76
1.3
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
16
15
10.78
14.66
4.8
5.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
108
480
2.36
14.60
7.7
3.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
62
210
3.05
14.31
6.1
3.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
552
4118
1.58
14.26
7.5
3.9
ng/l
62.0
59.4
0.07
439
3039
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
47
137
3.52
13.81
1.4
1.1
u/ml
324.5
308.4
0.11
37
78
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
54
173
3.21
13.68
1.9
1.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
899
7536
1.58
13.59
15.5
7.0
u/l
89.2
79.6
6.01
859
6989
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
68
251
2.80
13.46
1.7
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
68
251
2.80
13.46
1.7
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
48
145
3.40
13.36
1.4
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
366
2512
1.63
13.21
4.6
2.7
umol/l
2459.6
8665.6
2.00
311
2113
(3015377) Calcium [Moles/volume] in Serum or Plasma
477
3497
1.56
12.99
5.2
3.2
mmol/l
2.3
2.4
4.32
412
2977
(3037756) Immunofixation for Serum or Plasma
60
212
2.92
12.87
2.1
1.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
138
713
2.04
12.82
6.6
3.9
%
0.0
0.1
1.57
51
189
(3031040) Bacteria [#/volume] in Urine by Automated count
813
6706
1.54
12.82
7.6
4.8
e6/l
169.7
2183.4
1.85
20
125
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
87
372
2.43
12.82
3.3
2.5
g/l
7.5
7.5
0.01
58
279
(3036481) Cortisol [Moles/volume] in Serum or Plasma
150
800
1.99
12.76
2.9
2.0
nmol/l
388.1
375.3
0.33
140
722
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
29
63
4.68
12.62
1.1
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
135
697
2.04
12.57
2.2
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
39
107
3.72
12.54
7.1
4.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
82
346
2.46
12.44
3.4
2.6
g/l
3.4
3.2
0.69
55
274
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
86
371
2.41
12.43
3.3
2.5
g/l
4.2
3.8
0.59
55
269
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
34
85
4.08
12.42
1.7
1.1
u/l
70.3
53.0
0.96
23
58
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
336
2292
1.62
12.31
2.0
1.7
pmol/l
42806193.7
10276254.4
0.34
278
1849
(3024471) HLA-A [Type]
15
17
8.91
12.01
1.0
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
61
226
2.78
12.01
1.4
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
41
120
3.49
12.00
1.7
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
29
66
4.47
11.94
2.2
2.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
85
372
2.37
11.90
3.3
2.5
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
16
20
8.08
11.90
1.3
1.1
%
84.3
91.9
—
8
11
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
41
121
3.46
11.85
2.7
1.7
pg
30.7
32.7
1.32
41
121
(3002582) Erythrocytes [#/volume] in Urine
434
3174
1.54
11.68
5.5
3.2
e6/l
53.1
78.8
0.63
369
2492
(3052851) Hemolysis interference index of Serum or Plasma
73
301
2.51
11.64
7.3
3.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
46
148
3.18
11.61
6.3
3.5
%
1.9
1.6
0.21
33
116
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
44
138
3.26
11.57
1.9
1.6
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
93
429
2.25
11.54
9.3
5.6
%
1.8
1.7
0.58
83
404
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
76
321
2.45
11.51
3.2
2.9
g/l
0.8
1.4
0.67
57
275
(36304419) Bacteria [Presence] in Urine
390
2795
1.56
11.46
5.3
3.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
89
405
2.28
11.40
9.0
4.1
mmol/l
24.5
25.0
0.65
82
377
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
28
65
4.38
11.26
1.5
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
31
79
3.99
11.05
1.6
1.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
80
353
2.35
11.01
3.2
2.5
g/l
10.7
10.7
0.01
59
298
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
514
3936
1.50
10.97
3.2
2.2
nmol/l
75.5
78.1
1.34
448
3421
(21494890) Protein electrophoresis panel - 24 hour Urine
32
85
3.83
10.79
2.3
2.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
25
55
4.61
10.73
2.5
1.5
u/l
6.1
6.6
0.05
15
25
(3010421) pH of Blood
67
276
2.50
10.72
6.8
3.9
ph
7.4
7.4
0.42
58
223
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
43
140
3.14
10.66
1.7
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
14
17
8.31
10.62
1.2
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
56
212
2.71
10.61
1.4
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
84
385
2.26
10.59
1.9
1.5
u/ml
8.9
10.2
—
6
9
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
38
115
3.37
10.59
3.9
2.4
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
15
20
7.57
10.57
1.5
1.2
%
76.0
94.8
—
7
11
(40767503) Oxygen content in Capillary blood by calculation
53
196
2.77
10.50
4.3
2.4
%
14.7
16.2
1.76
27
99
(3042111) Morphology [Interpretation] in Bone marrow Narrative
42
137
3.13
10.38
1.8
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
27
65
4.22
10.38
1.6
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
89
422
2.19
10.34
9.6
5.7
%
0.9
0.9
0.31
79
398
(3030467) Casts [#/volume] in Urine by Automated count
395
2892
1.52
10.34
5.3
3.1
e6/l
0.5
0.5
0.33
336
2231
(21494434) Karyotype in Bone marrow
29
74
3.98
10.33
1.2
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
50
181
2.83
10.31
1.7
1.3
mmol/l
64.8
60.1
0.30
43
148
(3007164) IgA [Mass/volume] in Serum or Plasma
244
1600
1.64
10.30
1.7
1.4
g/l
2.8
2.6
0.62
151
924
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
42
138
3.11
10.26
1.8
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
58
228
2.61
10.22
7.1
4.3
mmol/l
3.0
2.9
0.10
45
158
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
80
365
2.27
10.20
3.0
2.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
153
883
1.83
10.20
2.5
1.7
%
1.9
1.5
2.67
125
758
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
46
160
2.94
10.19
1.7
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
36
108
3.40
10.18
1.9
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
64
265
2.49
10.14
4.8
3.2
mmol/l
25.1
25.3
0.08
57
230
(3027315) Oxygen [Partial pressure] in Blood
58
229
2.60
10.13
7.1
4.3
kpa
8.5
8.4
0.25
58
224
(3013290) Carbon dioxide [Partial pressure] in Blood
58
229
2.60
10.13
7.1
4.3
kpa
5.0
5.1
0.31
58
224
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
21
42
5.06
10.06
1.3
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
21
42
5.06
10.06
1.3
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
101
512
2.05
9.88
2.9
2.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
475
3650
1.47
9.66
6.1
3.7
e6/l
130.3
89.9
0.67
385
2667
(4035726)
141
807
1.83
9.65
1.5
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
68
297
2.36
9.60
4.0
3.1
nmol/l
1.0
0.9
0.59
44
231
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
179
1104
1.72
9.49
5.8
3.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
16
26
6.22
9.47
3.1
2.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
49
184
2.73
9.46
4.8
3.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
21
45
4.72
9.31
1.8
1.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
13
17
7.71
9.28
1.2
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
53
210
2.59
9.21
1.5
1.3
—
—
—
0
0
(3020891) Body temperature
86
424
2.10
9.07
7.5
4.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
176
1097
1.70
8.96
1.4
1.3
titre
530.9
506.9
0.06
33
236
(3006184) Hemoglobin [Mass/volume] in Capillary blood
53
214
2.54
8.88
3.5
2.1
g/l
111.1
131.3
3.82
39
151
(3022145) Colonoscopy Study observation
163
998
1.72
8.86
1.4
1.3
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
101
534
1.96
8.80
5.8
2.8
mmol/l
24.6
25.2
1.17
96
515
(3025159) Blasts/100 leukocytes in Blood
120
675
1.85
8.68
6.9
3.9
%
0.1
0.7
0.57
44
162
(3033799) Differential panel - Peritoneal fluid
15
25
6.06
8.66
2.3
2.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
21
48
4.43
8.63
2.1
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
21
48
4.43
8.63
2.1
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
53
218
2.49
8.55
1.3
1.2
titre
50.0
63.8
—
5
16
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
63
282
2.29
8.44
3.5
2.7
g/l
0.5
0.0
0.47
53
258
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
21
49
4.34
8.42
1.7
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
21
49
4.34
8.42
1.7
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
38
133
2.91
8.37
1.7
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
23
58
4.02
8.35
7.8
3.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
794
6810
1.41
8.32
7.0
4.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
35
118
3.02
8.23
1.6
1.6
g/l
0.6
0.7
0.33
24
90
(3019225) pH of Specimen
163
1020
1.68
8.17
8.8
3.9
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
10
11
9.15
8.09
17.0
11.0
mmol/l
5.3
6.5
—
10
11
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
13
20
6.55
8.07
1.2
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
59
262
2.31
8.06
3.2
2.8
g/l
0.0
0.0
0.00
50
242
(3012441) Differential panel - Pleural fluid
36
125
2.93
8.05
1.1
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
39
142
2.80
8.01
1.1
1.3
e6/l
1583.3
1322.6
0.26
28
101
(3025941) Bacteria identified in Stool by Culture
93
494
1.95
8.01
1.5
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
42
160
2.68
7.93
3.6
3.2
e9/l
4.3
4.4
0.06
42
160
(3003434) Protein [Mass/volume] in Pleural fluid
42
160
2.68
7.93
1.2
1.4
g/l
31.4
31.4
0.01
35
147
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
59
265
2.28
7.86
3.2
2.8
g/l
0.0
0.0
0.49
50
243
(3000494) Fungus identified in Specimen by Culture
172
1106
1.64
7.75
1.7
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
65
306
2.18
7.74
3.1
2.6
g/l
35.1
37.0
1.39
51
257
(3048879) Bone marrow aspiration report
13
21
6.24
7.72
1.5
1.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
26
76
3.47
7.69
2.1
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
685
5777
1.38
7.67
5.8
3.0
u/l
85.5
51.8
5.38
621
5296
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
42
163
2.63
7.65
4.7
3.4
%
61.9
58.9
0.81
42
163
(3028308) Erythrocytes [#/volume] in Pleural fluid
36
129
2.84
7.63
1.1
1.3
e6/l
251478.4
110851.0
0.31
23
79
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
11
15
7.39
7.56
1.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
58
3.84
7.54
2.1
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
68
331
2.11
7.45
5.9
3.7
mmol/l
3.9
3.9
0.26
61
304
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
16
6.92
7.15
2.4
1.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
36
134
2.73
7.13
1.3
1.6
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
25
75
3.38
7.12
4.2
2.8
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
13
7.74
7.12
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
32
113
2.88
6.98
1.3
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
85
462
1.90
6.87
2.7
1.9
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
26
82
3.21
6.86
1.6
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
507
4135
1.36
6.73
21.0
9.2
e9/l
0.0
0.0
0.40
433
3370
(3008295) Osmolality of Serum or Plasma
29
99
2.97
6.72
2.6
1.3
mosm/kgh2o
273.6
276.3
0.26
22
67
(3024891) Influenza virus A+B Ag [Presence] in Specimen
53
247
2.19
6.51
1.4
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
16
37
4.36
6.50
2.1
4.0
umol/l
140.6
95.4
—
10
25
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
30
107
2.84
6.44
1.8
1.8
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
33
124
2.70
6.44
4.3
4.1
umol/l
337.7
357.3
0.29
25
108
(1761868) Lipid panel - Serum or Plasma
209
2883
0.67
6.33
3.2
3.0
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
23
71
3.28
6.29
1.3
1.1
titre
120.0
95.0
—
6
12
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
5
18.11
6.27
8.8
8.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
78
426
1.88
6.23
2.4
1.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
17
43
3.99
6.17
2.1
1.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
69
363
1.95
6.16
3.2
2.8
g/l
0.4
0.2
1.20
27
132
(3020191) Ethanol [Moles/volume] in Serum or Plasma
21
62
3.43
6.15
1.8
1.5
promille
1.6
1.2
0.55
14
51
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
47
214
2.24
6.12
1.6
1.3
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
11
19
5.83
6.11
3.4
3.1
ml/dl
13.5
15.2
0.90
11
14
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
18
48
3.79
6.10
1.1
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
25
83
3.05
6.09
7.5
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
99
586
1.74
6.09
3.8
3.0
e9/l
4.2
4.2
0.02
67
435
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
34
135
2.56
5.98
1.7
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
16
40
4.04
5.90
2.3
2.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
34
136
2.54
5.89
1.7
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
72
391
1.89
5.87
3.2
3.2
u/ml
2287.3
10095.4
0.55
54
335
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
229
1664
1.45
5.87
4.2
3.0
e6/l
2.2
2.4
0.22
142
945
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
30
113
2.69
5.85
1.3
1.2
u/ml
2.5
2.3
0.10
12
32
(3044941) Cell count panel - Synovial fluid
37
155
2.43
5.83
1.8
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
11
20
5.54
5.81
2.4
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
34
137
2.52
5.81
1.7
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
21
65
3.27
5.74
2.4
2.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
16
41
3.94
5.72
1.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
16
41
3.94
5.72
1.6
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
16
41
3.94
5.72
1.6
1.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
41
3.94
5.72
1.0
1.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
378
3007
1.36
5.70
4.1
3.0
mmol/l
6.3
7.4
6.20
305
2474
(44806118)
29
109
2.70
5.68
1.4
1.6
—
—
—
0
0
(44790049)
29
109
2.70
5.68
1.4
1.6
—
—
—
0
0
(44790048)
29
109
2.70
5.68
1.4
1.6
—
—
—
0
0
(44790047)
29
109
2.70
5.68
1.4
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
33
133
2.52
5.64
1.7
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
33
133
2.52
5.64
1.7
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
57
291
2.00
5.57
1.4
1.4
ug/g
209.3
288.2
2.42
39
174
(3005988) Vibrio sp identified in Specimen by Organism specific culture
33
134
2.50
5.56
1.7
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
16
42
3.84
5.54
1.6
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
24
83
2.93
5.48
1.3
1.5
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
8
5
16.09
5.41
1.6
2.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
237
1760
1.42
5.37
4.1
2.8
e6/l
1.1
1.1
0.15
152
1035
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
27
101
2.71
5.35
1.6
1.8
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
10
18
5.59
5.32
7.3
8.7
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
8
11.32
5.29
2.3
1.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
42
198
2.16
5.08
2.1
3.4
u/ml
34.6
303.2
1.34
37
183
(3040151) Glucose [Moles/volume] in Capillary blood
30
122
2.49
5.06
12.8
6.1
mmol/l
8.1
7.3
0.62
25
101
(3006922) Hepatitis E virus Ab [Presence] in Serum
16
45
3.59
5.05
1.0
1.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
792
7077
1.29
4.90
5.7
4.0
mm/h
20.5
13.3
15.90
718
6466
(3044927) Protein electrophoresis panel - Urine
29
118
2.49
4.89
1.2
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
16
47
3.43
4.75
2.1
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
37
171
2.20
4.71
2.8
2.1
u/l
2374.2
1880.7
0.08
18
66
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
29
121
2.43
4.66
1.3
1.2
u/ml
3.7
7.2
0.69
13
54
(3017354) Segmented neutrophils/100 leukocytes in Blood
25
97
2.61
4.65
5.8
3.0
%
55.1
53.6
0.11
14
68
(40760892) CBC W Ordered Manual Differential panel - Blood
252
1936
1.37
4.65
6.8
4.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
12
29
4.17
4.63
8.7
5.4
%
59.8
46.2
1.06
12
29
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
238
1813
1.38
4.62
1.3
1.2
u/ml
2.8
1.8
0.23
52
469
(3011288) Drugs identified in Urine by Screen method
29
122
2.41
4.58
9.6
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
20
70
2.89
4.50
2.3
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
17
54
3.18
4.49
1.6
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
17
54
3.18
4.49
1.6
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
17
54
3.18
4.49
1.6
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
17
54
3.18
4.49
1.6
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
78
473
1.69
4.46
3.7
3.2
pmol/l
4.1
4.5
2.08
68
410
(3029075) Extractable nuclear Ab panel - Serum
11
26
4.26
4.36
1.0
1.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
30
132
2.30
4.31
2.0
2.2
mg/l
26.5
27.6
0.03
11
37
(3034426) Prothrombin time (PT)
10
22
4.57
4.30
1.2
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
375
3087
1.30
4.27
4.5
3.8
mg/mmol
18.1
8.5
2.05
255
1950
(3024139) IgG subclass 3 [Mass/volume] in Serum
19
67
2.86
4.23
1.3
1.2
g/l
0.4
0.4
—
10
46
(3028192) IgG subclass 2 [Mass/volume] in Serum
19
67
2.86
4.23
1.3
1.2
g/l
3.2
2.6
—
10
46
(3027135) IgG subclass 1 [Mass/volume] in Serum
19
67
2.86
4.23
1.3
1.2
g/l
6.2
7.5
—
10
47
(3051611) Lipemic interference index of Serum or Plasma
25
102
2.48
4.23
7.7
3.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
31
141
2.23
4.14
6.5
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
23
92
2.53
4.06
1.5
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
23
92
2.53
4.06
1.5
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
23
92
2.53
4.06
1.5
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
19
69
2.78
4.03
3.4
1.5
%
9.2
10.9
0.95
19
69
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
51
282
1.84
4.02
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
51
282
1.84
4.02
1.4
1.2
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
7
7
10.04
4.01
1.0
1.7
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
7
7
10.04
4.01
1.3
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
47
255
1.87
3.93
1.6
2.0
—
—
—
0
0
(4062490)
19
70
2.74
3.93
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
51
285
1.82
3.89
1.4
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
52
293
1.81
3.87
1.8
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
27
561
0.47
3.84
1.6
1.8
—
—
—
0
0
(3002256) Pathology report gross observation
167
1238
1.40
3.81
1.3
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
11
29
3.82
3.80
3.9
2.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
351
2904
1.28
3.79
4.0
3.1
mg/l
1164.4
223.0
1.47
248
1844
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
259
2058
1.32
3.78
4.1
3.0
mmol/l
2.5
2.5
1.88
220
1783
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
29
134
2.19
3.75
1.2
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
45
3.13
3.65
1.8
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
31
149
2.11
3.65
3.5
2.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
33
163
2.05
3.62
6.2
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
17
62
2.76
3.59
1.1
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
27
124
2.20
3.55
1.2
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
9
17
5.32
3.51
6.4
8.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
440
3774
1.25
3.46
2.4
2.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
191
2435
0.75
3.39
1.9
1.6
mmol/l
1.5
1.3
1.04
163
2014
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
31
154
2.04
3.37
1.6
1.5
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
14
5.74
3.34
1.4
2.1
umol/l
13.0
14.5
—
8
14
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
30
148
2.05
3.32
3.8
2.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
34
176
1.96
3.31
6.0
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
134
981
1.41
3.30
2.7
2.1
ug/g
272.1
144.7
1.22
110
766
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
6
7
8.60
3.26
1.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
34
177
1.94
3.26
6.0
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
92
629
1.50
3.25
1.1
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
34
178
1.93
3.21
6.0
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
32
164
1.97
3.21
1.2
1.2
—
2.1
—
0
11
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
11
33
3.35
3.19
1.3
1.7
mmol/l
7.2
8.1
0.42
11
19
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
11
33
3.35
3.19
1.0
1.2
—
18.4
—
0
7
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
15
5.36
3.19
5.8
9.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
287
2362
1.27
3.18
1.5
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
28
137
2.07
3.18
1.1
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
17
67
2.56
3.13
1.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
14
50
2.82
3.09
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
71
465
1.56
3.06
3.0
2.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
30
155
1.96
2.96
2.0
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
18
76
2.39
2.90
1.1
1.1
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
7
13
5.41
2.87
1.4
1.1
ng/l
50.2
261.1
—
7
8
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
9
6.69
2.87
1.5
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
17
71
2.41
2.80
1.2
1.2
titre
—
—
—
0
0
(40761535) Cells panel - Urine sediment
121
898
1.38
2.78
4.4
3.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
30
534
0.55
2.72
1.5
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
33
182
1.83
2.71
1.7
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
41
242
1.72
2.69
2.0
1.7
e6/l
19915.6
17271.4
0.11
28
174
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
17
73
2.35
2.65
1.3
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
63
417
1.54
2.63
1.2
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
15
4.69
2.60
1.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
11
38
2.91
2.58
1.8
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
25
3.62
2.57
1.2
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
113
841
1.38
2.57
6.6
3.2
mmol/l
1.2
1.2
1.25
104
712
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
5
7
7.17
2.55
1.4
1.0
—
—
—
0
0
(3025315) Body weight
5
7
7.17
2.55
7.6
3.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
6
11
5.47
2.54
5.2
5.2
—
—
—
0
0
(4268621)
18
82
2.21
2.48
2.1
2.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
16
4.39
2.47
1.0
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
10
34
2.96
2.41
1.1
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
27
3.35
2.39
1.4
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
11
40
2.76
2.37
2.9
2.7
u/ml
3469.5
958.1
1.00
11
40
(3001729) Color of Synovial fluid
5
8
6.27
2.37
1.0
1.4
—
—
—
0
0
(4306422)
21
104
2.04
2.37
1.3
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
8
22
3.65
2.36
2.3
3.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
20
384
0.51
2.36
1.3
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
33
547
0.59
2.34
1.2
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
26
140
1.87
2.33
2.2
2.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
174
2126
0.79
2.20
2.8
3.2
ug/l
0.9
0.8
0.29
134
1497
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
13
54
2.42
2.20
3.7
2.4
—
—
—
0
0
(1002224) Polysomnography panel
13
281
0.46
2.17
1.0
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
999
9518
1.19
2.14
42.0
15.3
mg/l
26.6
26.4
0.07
926
7653
(40761536) Microorganisms panel - Urine sediment
110
842
1.33
2.13
6.4
3.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
37
2.72
2.10
1.3
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
8
25
3.21
2.09
1.1
1.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
16
75
2.15
2.09
1.2
2.0
mmol/l
7.9
6.9
—
7
47
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
14
62
2.27
2.08
2.9
1.5
g/l
0.9
1.0
0.99
14
62
(3027944) Amphetamines [Presence] in Urine
30
176
1.72
2.07
5.3
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
31
184
1.70
2.05
1.2
1.3
miu/ml
261.5
224.6
—
10
92
(3044290) Cell count panel - Cerebral spinal fluid
27
154
1.77
2.05
1.4
1.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
6
15
4.01
2.04
1.0
1.3
umol/l
46.5
53.3
—
6
15
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
23
125
1.85
2.03
1.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
21
111
1.91
2.01
3.9
3.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
10
38
2.64
2.01
1.1
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
21
3.35
1.96
1.7
2.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
42
274
1.55
1.94
1.4
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
19
99
1.93
1.90
1.4
1.3
mmol/l
5.8
7.4
4.67
14
67
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
22
3.19
1.88
1.7
2.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
21
114
1.86
1.87
1.2
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
17
3.54
1.84
1.5
1.4
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
5
12
4.18
1.82
4.0
2.3
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
12
4.18
1.82
1.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
12
4.18
1.82
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
260
2984
0.84
1.76
4.2
4.7
%
23.8
21.8
0.92
117
1550
(3017704) Immunofixation for Urine
12
54
2.23
1.74
1.8
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
12
54
2.23
1.74
5.0
4.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
301
2644
1.18
1.72
6.1
4.2
estimate
0.0
0.0
0.88
110
854
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
13
61
2.14
1.72
1.6
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
13
3.86
1.71
1.2
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
10
42
2.39
1.68
6.8
3.9
u/l
223.9
205.0
—
10
42
(3014891) Appearance of Pleural fluid
6
19
3.17
1.66
1.2
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
25
2.81
1.65
1.0
1.0
miu/ml
2423.1
1819.1
—
7
25
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
856
8977
0.87
1.64
4.7
4.4
mmol/l
1.4
1.5
7.80
765
8081
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
37
246
1.52
1.61
2.5
2.3
ug/min
103.7
93.0
0.10
25
151
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
85
1088
0.77
1.60
1.6
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
38
255
1.50
1.59
1.4
1.6
iu/ml
0.3
23.6
0.49
17
51
(3004716) Salmonella sp identified in Stool by Organism specific culture
57
414
1.39
1.59
1.4
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
20
3.01
1.58
1.5
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
57
2.12
1.55
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
57
2.12
1.55
1.2
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
12
57
2.12
1.55
1.2
1.6
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
57
2.12
1.55
1.2
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
19
107
1.79
1.55
1.3
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
246
2146
1.18
1.53
6.4
4.4
kg/l
1.0
1.0
0.00
45
304
(3001019) Free T4 and TSH panel - Serum or Plasma
19
321
0.59
1.53
1.7
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
19
108
1.77
1.51
1.6
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
58
2.08
1.49
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
58
2.08
1.49
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
58
2.08
1.49
1.2
1.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
9
37
2.44
1.48
1.4
1.1
%
—
71.2
—
0
5
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
892
9301
0.88
1.46
5.1
5.1
mmol/l
2.3
2.6
19.50
790
8397
(3035350) Ketones [Presence] in Urine by Test strip
516
4773
1.13
1.42
5.5
3.8
estimate
0.0
0.0
0.00
116
890
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
16
88
1.83
1.41
1.6
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
69
528
1.32
1.41
1.9
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
67
1.95
1.38
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
869
9059
0.88
1.36
4.7
4.5
mmol/l
4.2
4.5
18.92
781
8221
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
82
1.84
1.36
1.3
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
75
1.88
1.34
1.2
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
13
234
0.55
1.34
1.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
13
68
1.92
1.33
5.1
2.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
148
0.47
1.32
1.3
1.7
—
—
—
0
0
(4146454)
19
113
1.69
1.32
2.7
2.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
286
2556
1.15
1.31
5.5
3.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
24
2.51
1.30
1.2
1.0
—
—
—
0
0
(4094501)
13
231
0.56
1.29
1.1
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
12
62
1.94
1.28
10.4
16.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
44
2.05
1.27
1.4
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
519
4829
1.12
1.27
5.6
3.9
estimate
0.0
0.0
0.80
112
878
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
9
45
2.01
1.23
2.1
2.1
e6/l
395.4
498.6
—
9
40
(3013512) EKG study
335
3040
1.14
1.23
6.1
4.1
—
—
—
0
0
(3004451) EKG impression Narrative
10
49
2.05
1.22
1.6
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
747
7112
1.11
1.18
4.4
3.8
pmol/l
15.0
14.9
0.32
664
6330
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
36
0.00
1.14
0.0
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
113
0.44
1.13
1.2
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
143
1229
1.18
1.10
4.6
4.5
%
34.4
32.9
0.78
106
782
(3021601) Nitrite [Presence] in Urine by Test strip
510
4772
1.11
1.10
7.2
5.2
estimate
0.0
0.0
0.00
112
888
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
7
136
0.51
1.10
2.1
2.0
pmol/l
212.0
202.3
—
7
127
(4198724)
5
21
2.39
1.09
3.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
42
557
0.75
1.08
1.8
1.8
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
11
59
1.87
1.07
1.0
1.4
ug/l
2.8
3.3
0.19
11
51
(3011397) Hemoglobin [Presence] in Urine by Test strip
251
2257
1.14
1.06
4.7
3.9
—
—
—
0
0
(4015189)
7
33
2.13
1.05
2.1
2.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
13
75
1.74
1.03
1.1
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
110
0.45
1.00
1.2
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
110
0.45
1.00
1.2
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
49
1.84
0.98
1.0
1.2
nmol/l
144.1
140.6
—
9
49
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
23
2.18
0.98
2.4
2.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
36
1.95
0.97
2.1
2.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
36
1.95
0.97
2.1
2.5
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
7
37
1.90
0.94
1.3
1.1
%
39.6
24.6
—
7
32
(3009542) Hematocrit [Volume Fraction] of Blood
863
8334
1.10
0.93
45.7
16.5
%
35.0
38.9
19.09
529
5442
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
12
70
1.72
0.92
1.2
1.3
—
75.0
—
0
8
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
28
201
1.40
0.91
1.6
1.7
iu/l
5.4
5.9
—
8
62
(3005322) IgE [Units/volume] in Serum or Plasma
62
501
1.25
0.91
1.2
1.2
u/ml
244.1
267.4
0.07
54
455
(40757373) Influenza virus identified in Isolate
6
29
2.07
0.89
1.3
1.5
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
8
42
1.91
0.88
1.4
1.3
%
2.8
3.3
—
8
34
(3005570) Glucose [Moles/volume] in Urine
18
119
1.52
0.88
2.3
2.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
16
103
1.56
0.87
1.9
1.4
e6/l
139994.5
179576.0
0.09
11
72
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
43
1.87
0.87
6.1
6.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
30
2.00
0.87
1.3
1.5
ug/l
14.0
8.8
—
6
30
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
49
613
0.79
0.86
1.9
1.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
35
265
1.33
0.85
1.6
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
148
0.61
0.79
1.8
1.5
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
8
48
1.67
0.78
1.3
1.3
%
49.0
62.3
—
8
34
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
395
3709
1.09
0.77
6.0
4.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
54
1.67
0.74
1.1
3.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
39
1.80
0.72
1.9
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
20
142
1.41
0.72
1.3
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
107
1219
0.87
0.72
1.3
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
41
1.71
0.70
1.3
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
843
8669
0.93
0.69
4.4
4.0
mmol/l
1.3
1.3
0.92
752
7736
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
88
761
1.17
0.69
3.4
2.8
ml/min/173m2
52.3
62.6
1.52
53
328
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
27
1.85
0.68
1.2
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
27
1.85
0.68
1.2
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
894
9170
0.92
0.68
5.4
4.7
mmol/l
6.3
6.0
5.58
797
8182
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
18
127
1.42
0.68
1.6
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
792
7679
1.08
0.67
52.3
18.3
%
15.0
13.8
52.72
777
7490
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
79
914
0.86
0.66
1.6
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
14
202
0.69
0.66
1.3
1.3
—
—
—
0
0
(4034850)
24
316
0.76
0.66
23.0
11.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
70
1.58
0.65
2.9
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1011
9904
1.08
0.63
48.9
18.2
mmol/l
138.8
139.6
15.18
977
9593
(3016018) Differential panel - Cerebral spinal fluid
12
79
1.52
0.62
1.7
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
32
253
1.27
0.61
4.6
3.8
mg/l
34.3
29.7
0.18
20
164
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
130
1.39
0.61
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
527
5050
1.07
0.60
3.0
2.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
54
639
0.84
0.60
2.1
2.1
nmol/l
9.8
12.2
0.96
40
554
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
26
201
1.30
0.59
1.3
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
45
373
1.21
0.58
1.3
1.1
—
168.7
—
0
7
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
53
1.51
0.58
10.8
3.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1012
9926
1.08
0.58
49.3
18.3
mmol/l
4.0
4.0
0.78
975
9603
(3045424) Erythrocytes [Presence] in Urine
10
150
0.66
0.58
1.6
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
17
123
1.39
0.58
1.1
1.1
iu/ml
17.5
93.3
—
6
25
(40768795) Lymph node Pathology biopsy report
12
82
1.47
0.54
1.6
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
61
1.48
0.53
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
61
1.48
0.53
1.1
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
750
7704
0.94
0.53
55.7
19.9
g/l
326.9
331.7
31.56
737
7611
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
99
0.60
0.52
1.5
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
14
100
1.40
0.52
1.9
1.2
nmol/l
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
134
0.67
0.52
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
134
0.67
0.52
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
134
0.67
0.52
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
134
0.67
0.52
1.6
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
92
1.42
0.50
1.2
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
46
1.52
0.48
1.4
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
20
256
0.78
0.48
1.9
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
35
416
0.84
0.44
2.4
1.9
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
10
69
1.45
0.44
1.0
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
697
6794
1.05
0.43
5.6
4.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
858
8747
0.95
0.42
7.6
6.0
mmol/mol
41.9
40.4
3.30
782
7960
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
32
1.56
0.42
3.6
2.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
70
1.43
0.41
1.7
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
28
232
1.21
0.40
1.4
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
45
390
1.16
0.40
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
35
1.43
0.39
1.2
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
19
237
0.80
0.39
1.7
1.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
66
1.37
0.38
1.4
2.7
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
5
36
1.39
0.38
1.2
1.9
nmol/l
1.1
6.6
—
5
29
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
14
107
1.31
0.37
1.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
37
1.35
0.37
1.2
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
992
9784
1.05
0.35
41.2
14.5
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
6
43
1.40
0.35
1.2
5.9
—
80.5
—
0
10
(3022621) pH of Urine by Test strip
75
681
1.11
0.34
5.5
3.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
86
0.70
0.33
1.7
1.5
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
6
47
1.28
0.32
1.3
1.1
u/l
194.5
526.4
—
6
42
(4281824)
12
92
1.31
0.32
1.5
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
154
1452
1.07
0.31
1.3
1.2
iu/ml
39.7
37.2
0.09
49
466
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
27
230
1.18
0.31
1.4
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
130
1385
0.93
0.31
1.3
1.2
u/ml
5.0
12.8
2.24
36
507
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
7
54
1.30
0.30
1.1
1.1
mg/l
46.7
40.1
—
7
45
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
75
1.34
0.30
1.0
1.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
873
8606
1.04
0.28
5.4
4.6
mu/l
2.1
2.1
0.10
784
7721
(3013139) Helicobacter pylori Ag [Presence] in Stool
62
565
1.10
0.28
1.1
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
139
1312
1.07
0.28
17.1
8.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
76
1.32
0.28
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
26
301
0.86
0.28
1.5
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
357
3683
0.96
0.28
4.9
5.4
ug/l
3.1
4.4
0.53
312
3262
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
214
0.84
0.26
2.1
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1003
9925
1.04
0.26
19.7
10.3
u/l
27.1
25.1
0.61
967
9490
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
48
528
0.91
0.25
1.1
1.2
iu/ml
73.5
137.5
0.81
18
204
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
40
1.25
0.22
1.4
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
79
1.27
0.22
1.8
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
41
1.22
0.22
6.6
3.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1030
10388
0.96
0.22
61.8
22.3
g/l
118.7
133.6
118.94
1006
10162
(3010813) Leukocytes [#/volume] in Blood
1030
10388
0.96
0.22
61.3
22.2
e9/l
7.4
6.9
2.77
997
10023
(3038515) Glucose [Moles/volume] in Venous blood
28
248
1.13
0.21
4.1
3.0
mmol/l
8.0
7.9
0.06
28
243
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
10
0.00
0.21
0.0
1.4
—
21.3
—
0
5
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
12
98
1.23
0.21
1.7
2.3
u/field
0.8
1.8
—
6
29
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
15
126
1.19
0.21
1.7
1.7
—
—
—
0
0
(4027681)
5
43
1.16
0.21
1.2
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1030
10384
0.97
0.20
61.1
22.2
e12/l
4.0
4.4
85.76
997
10023
(3035941) MCH [Entitic mass]
1030
10383
0.97
0.20
60.8
22.1
pg
30.0
30.4
8.60
1006
10155
(3024731) MCV [Entitic volume]
1030
10382
0.97
0.20
60.9
22.1
fl
91.4
91.5
0.19
1006
10155
(3007461) Platelets [#/volume] in Blood
1030
10381
0.97
0.19
61.1
22.2
e9/l
237.6
243.0
1.16
1002
10061
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
45
414
1.09
0.19
3.7
2.9
u/ml
33.9
66.6
1.42
45
397
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
14
118
1.19
0.19
1.6
1.6
%
55.9
66.5
—
9
79
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
6
52
1.15
0.19
1.2
1.1
mg/l
256.8
251.8
—
6
46
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
109
1.19
0.18
1.2
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
7
60
1.17
0.17
8.9
2.2
%
13.4
13.2
—
7
60
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
110
1.18
0.17
1.9
1.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
5
69
0.72
0.17
1.8
2.3
—
82.6
—
0
11
(4024509)
11
92
1.20
0.16
1.9
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
23
206
1.12
0.16
1.4
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
78
0.77
0.15
1.0
1.8
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
83
1.21
0.15
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
84
1.19
0.14
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
100
0.80
0.13
1.0
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
28
258
1.09
0.12
4.1
3.0
mmol/l
1.8
1.6
0.27
28
252
(3000330) Specific gravity of Urine by Test strip
53
556
0.95
0.10
4.2
3.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
46
1.09
0.09
1.2
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
11
97
1.14
0.09
1.1
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
21
226
0.93
0.08
2.9
2.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
74
0.81
0.07
1.7
1.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
8
76
1.05
0.07
1.1
1.1
nmol/l
2.4
1.6
—
8
66
(3023511) Choriogonadotropin [Units/volume] in Urine
8
92
0.87
0.06
2.1
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
100
0.90
0.06
1.0
1.1
—
—
—
0
0
(4010399)
69
672
1.03
0.05
1.5
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
208
1.06
0.05
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
17
160
1.06
0.04
2.5
2.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
33
319
1.04
0.03
5.0
4.5
—
—
—
0
0
(3000492) Spirometry study
83
817
1.02
0.03
1.6
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
20
209
0.96
0.03
1.3
1.5
mu/l
276.8
289.3
0.11
20
183
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
876
8775
1.00
0.02
36.3
14.4
ml/min/173m2
70.6
75.5
5.80
757
7270
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
113
1.06
0.02
1.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
26
255
1.02
0.00
1.1
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.6
—
465.6
—
0
5
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
64.0
—
0
8
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
2.6
—
0
5
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
12.8
—
0
8
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
8.2
—
0
7
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
65
0.92
0.00
1.0
1.0
—
—
—
0
0
(4211845)
5
49
1.02
0.00
6.6
3.0
—
—
—
0
0
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
64
0.94
0.00
1.2
1.2
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_ACUTEPOSTBLEEDANAEMIA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_ACUTEPOSTBLEEDANAEMIA | 2.744 [2.4, 3.14] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.011 |
During the follow-up period (1.1.1998 — 31.12.2019), 3269 out of 5439 females with D3_ACUTEPOSTBLEEDANAEMIA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_ACUTEPOSTBLEEDANAEMIA | 3.312 [2.83, 3.88] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.044 |
During the follow-up period (1.1.1998 — 31.12.2019), 3031 out of 4720 males with D3_ACUTEPOSTBLEEDANAEMIA died.
Mortality risk
Mortality risk for people of age
years, who have D3_ACUTEPOSTBLEEDANAEMIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.139% | 0.678% |
| 5 | 1.314% | 4.017% |
| 10 | 3.311% | 10.539% |
| 15 | 6.126% | 19.392% |
| 20 | 10.911% | 30.574% |
Relationships between endpoints
↥Index endpoint: D3_ACUTEPOSTBLEEDANAEMIA – Acute posthaemorrhagic anaemia
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data